Scope
Reference
CM/PHG/24/5716
Description
NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.
Periods of call-offs under the framework agreement:
CM/PHG/24/5716/01– Hospital Only Products - Lenalidomide
CESW: (Midlands and Southwest): 1st June 2026 – 31st May 2028
NWLN: (Northwest and London North): 1st June 2026 – 31st May 2028
LSNE: (London South and Northeast): 1st June 2026 – 31st May 2028
CM/PHG/24/5716/02 – Hospital Only Products - Pomalidomide
CESW: (Midlands and Southwest): 1st June 2026 – 31st May 2028
NWLN: (Northwest and London North): 1st June 2026 – 31st May 2028
LSNE: (London South and Northeast): 1st June 2026 – 31st May 2028
CM/PHG/24/5716/03 – Hospital Only Products - Thalidomide
CESW: (Midlands and Southwest): 1st June 2026 – 31st May 2028
NWLN: (Northwest and London North): 1st June 2026 – 31st May 2028
LSNE: (London South and Northeast): 1st June 2026 – 31st May 2028
Commercial tool
Establishes a framework
Total value (estimated)
- £196,203,120 excluding VAT
- £235,443,744 including VAT
Contract dates (estimated)
- 1 June 2026 to 31 May 2028
- Possible extension to 31 May 2030
- 4 years
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Engagement
Engagement deadline
30 January 2026
Engagement process description
NHS England is advising suppliers of an upcoming tender for the NHS Generics Pharmaceuticals – Lenalidomide, Pomalidomide & Thalidomide to commence on 1st June 2026 for 24 months with options to extend for a maximum total contract period of 48 months. This procurement will consist Lenalidomide, Pomalidomide and Thalidomide products across all regions of the country. The purpose of this notice is to inform existing and potential new suppliers of this procurement. Useful information for suppliers can be found here www.england.nhs.uk/medicines-2/medicines-value-and-access/medicines-procurement-and-supply-chain/ . Specific information regarding the products included in this procurement will be provided in the ITO which will be issued shortly.
Participation
Particular suitability
Small and medium-sized enterprises (SME)
Submission
Publication date of tender notice (estimated)
2 February 2026
Contracting authority
NHS England
- Public Procurement Organisation Number: PDPT-3135-BWWY
Wellington House, 133-135 Waterloo Rd
London
SE1 8UG
United Kingdom
Email: england.generics@nhs.net
Website: https://www.england.nhs.uk/
Region: UKI45 - Lambeth
Organisation type: Public authority - central government